NasdaqGS - Nasdaq Real Time Price USD

Aclaris Therapeutics, Inc. (ACRS)

Compare
2.5100 +0.4600 (+22.44%)
As of 10:47 AM EST. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
197,405.0000
254,596.0000
251,211.0000
70,784.0000
Total Liabilities Net Minority Interest
40,226.0000
56,975.0000
53,870.0000
33,134.0000
Total Equity Gross Minority Interest
157,179.0000
197,621.0000
197,341.0000
37,650.0000
Total Capitalization
157,179.0000
197,621.0000
197,341.0000
48,303.0000
Common Stock Equity
157,179.0000
197,621.0000
197,341.0000
37,650.0000
Capital Lease Obligations
426.0000
684.0000
693.0000
603.0000
Net Tangible Assets
156,910.0000
190,648.0000
190,293.0000
30,527.0000
Working Capital
97,904.0000
209,612.0000
182,101.0000
42,619.0000
Invested Capital
157,179.0000
197,621.0000
197,341.0000
48,303.0000
Tangible Book Value
156,910.0000
190,648.0000
190,293.0000
30,527.0000
Total Debt
426.0000
684.0000
693.0000
11,256.0000
Share Issued
70,894.8890
66,688.6470
61,228.4460
45,109.3140
Ordinary Shares Number
70,894.8890
66,688.6470
61,228.4460
45,109.3140
12/31/2020 - 10/6/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers